Cefpodoxime proxetil

Edina Avdic, Pharm.D., BCPS, Paul A. Pham, Pharm.D.

INDICATIONS

FDA

NON-FDA APPROVED USES

  • Prophylaxis in neutropenic fever in patients who are intolerant of fluoroquinolones
  • Oral alternative therapy for pyelonephritis without bacteremia in patients who are resistant to fluoroquinolones or trimethoprim/sulfamethoxazole.
    • IDSA recommends that if oral β-lactams are to be empirically used, initial intravenous dose of a long-acting parenteral antimicrobial such as 1 g of ceftriaxone or a consolidated 24-h dose of an aminoglycoside be administered first[1].

There's more to see -- the rest of this topic is available only to subscribers.

Last updated: March 4, 2018